BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25625474)

  • 1. Application of vibrational spectroscopy, thermal analyses and X-ray diffraction in the rapid evaluation of the stability in solid-state of ranitidine, famotidine and cimetidine.
    Jamrógiewicz M; Ciesielski A
    J Pharm Biomed Anal; 2015 Mar; 107():236-43. PubMed ID: 25625474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
    Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
    J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the influence of β-cyclodextrin derivatives on the physical stability of famotidine.
    Jamrógiewicz M; Milewska K
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Aug; 219():346-357. PubMed ID: 31055241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug.
    Gupta V; Gupta M; Madan AK
    PDA J Pharm Sci Technol; 2009; 63(1):58-70. PubMed ID: 19455942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro availability of metformin in presence of h(2) receptor antagonists.
    Sultana N; Arayne MS; Ahmed N
    Pak J Pharm Sci; 2006 Jan; 19(1):28-34. PubMed ID: 16632449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Slow Relaxation Dynamics in the Amorphous Pharmaceutical Drugs Cimetidine, Nizatidine, and Famotidine.
    Viciosa MT; Moura Ramos JJ; Diogo HP
    J Pharm Sci; 2016 Dec; 105(12):3573-3584. PubMed ID: 27773524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Spectroscopic studies on drug interaction of cefpodoxime proxetil and H2 receptor blockers.
    Iqbal S; Hassan S; Hassan A; Ali M; Nazim U; Zaheer E; Ahmed A; Hussain K; Shereen -; Furqan H
    Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):881-887. PubMed ID: 31103987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical fate of pharmaceuticals in the environment: cimetidine and ranitidine.
    Latch DE; Stender BL; Packer JL; Arnold WA; McNeill K
    Environ Sci Technol; 2003 Aug; 37(15):3342-50. PubMed ID: 12966980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interactions of captopril with H2-receptor antagonists.
    Sultana N; Arayne MS; Quraish R
    Pak J Pharm Sci; 2007 Apr; 20(2):132-9. PubMed ID: 17416569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosinopril H(2)-receptor antagonists interaction studies by derivative spectroscopy.
    Sultana N; Arayne MS; Sana A
    Pak J Pharm Sci; 2007 Jan; 20(1):19-25. PubMed ID: 17337423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion-exchange complex of famotidine: sustained release and taste masking approach of stable liquid dosage form.
    Aman RM; Meshali MM; Abdelghani GM
    Drug Discov Ther; 2014 Dec; 8(6):268-75. PubMed ID: 25639307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora.
    Basit AW; Newton JM; Lacey LF
    Int J Pharm; 2002 Apr; 237(1-2):23-33. PubMed ID: 11955801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The development of co-amorphous drug systems].
    Yao J; Shi NQ; Wang XL
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Validated Comparative Stability-Indicating Assay Method for Some H2-Receptor Antagonists.
    Ahmed S; Elshaboury SR; Mohamed NA; Farrag S
    J Chromatogr Sci; 2017 Sep; 55(8):818-831. PubMed ID: 28486578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress degradation studies of nelfinavir mesylate by Fourier transform infrared spectroscopy.
    Singh P; Mehrotra R; Bakhshi AK
    J Pharm Biomed Anal; 2010 Nov; 53(3):287-94. PubMed ID: 20399586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The latest development of the research on Chinese medicine by molecular vibrational spectroscopy].
    Sun S; Zhou Q; Yu J; Hu X
    Guang Pu Xue Yu Guang Pu Fen Xi; 2000 Apr; 20(2):199-202. PubMed ID: 12953487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro availability studies of enoxacin in presence of H2 receptor antagonists.
    Arayne MS; Sultana N; Haroon U; Hamza E
    Pak J Pharm Sci; 2007 Jul; 20(3):235-43. PubMed ID: 17545110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.